Skip to main content
Livermore
Livermore
ZHEN

Forbes J M & Co LLP

SEC CIK
0001067532
Latest filing
Jul 20, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Forbes J M & Co LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
140,528
Value
$12.8M
% of portfolio
1.0%
Quarters held
22
Since Q1 2021
Holdings of ABT by Forbes J M & Co LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026140,528$12.8M1.0%−681−0.5%ReducedHolders
Q1 2026141,209$14.5M1.2%+1,675+1.2%AddedHolders
Q4 2025139,534$17.5M1.4%+529+0.4%AddedHolders
Q3 2025139,005$18.6M1.5%+929+0.7%AddedHolders
Q2 2025138,076$18.8M1.7%−1,808−1.3%ReducedHolders
Q1 2025139,884$18.6M1.8%+4,281+3.2%AddedHolders
Q4 2024135,603$15.3M1.5%+415+0.3%AddedHolders
Q3 2024135,188$15.4M1.5%−734−0.5%ReducedHolders
Q2 2024135,922$14.1M1.4%+1,741+1.3%AddedHolders
Q1 2024134,181$15.3M1.7%−1,396−1.0%ReducedHolders
Q4 2023135,577$14.9M1.7%+1,219+0.9%AddedHolders
Q3 2023134,358$13.0M1.7%+1,231+0.9%AddedHolders
Q2 2023133,127$14.5M1.8%−19,185−12.6%ReducedHolders
Q1 2023152,312$15.4M2.1%+2,872+1.9%AddedHolders
Q4 2022149,440$16.4M2.4%+333+0.2%AddedHolders
Q3 2022149,107$14.4M2.3%+2,018+1.4%AddedHolders
Q2 2022147,089$16.0M2.4%−532−0.4%ReducedHolders
Q1 2022147,621$17.5M2.2%−503−0.3%ReducedHolders
Q4 2021148,124$20.8M2.4%−47,881−24.4%ReducedHolders
Q3 2021196,005$23.2M2.9%+2,118+1.1%AddedHolders
Q2 2021193,887$22.5M2.8%+197+0.1%AddedHolders
Q1 2021193,690$23.2M3.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.